Back
National Bank of Canada Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
62
NTIOF
National Bank of Canada
Last Price:
$125.92
Seasonality Move:
1.83%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$83.03
Seasonality Move:
-32.16%
Buy
62
National Bank of Canada (NTIOF)
is a Buy
Is National Bank of Canada a Buy, Sell or Hold?
-
The current National Bank of Canada [NTIOF] share price is $125.92. The Score for NTIOF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NTIOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTIOF Stock Price Chart
What is National Bank of Canada's stock price today?
-
The National Bank of Canada share price today is $125.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTIOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.88The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
NTIOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.13 | Buy |
| Relative Strength Index (14 RSI): | 75.37 | Buy |
| Chaikin Money Flow: | 31811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (116.52 - 125.08) | Buy |
| Bollinger Bands (100): | (105.14 - 117.66) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -145421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.39 - 83.51) | Buy |
| Bollinger Bands (100): | (41.65 - 69.37) | Buy |
NTIOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.59 | Buy |
| 20-day SMA: | 122.14 | Buy |
| 50-day SMA: | 115.67 | Buy |
| 200-day SMA: | 101.77 | Buy |
| 8-day EMA: | 125.18 | Buy |
| 20-day EMA: | 122.45 | Buy |
| 50-day EMA: | 117.35 | Buy |
| 200-day EMA: | 105.4 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.2 | Sell |
| 20-day SMA: | 75.43 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 43.03 | Buy |
| 8-day EMA: | 83.79 | Sell |
| 20-day EMA: | 77.26 | Buy |
| 50-day EMA: | 67.4 | Buy |
| 200-day EMA: | 47.62 | Buy |
National Bank of Canada Earnings Growth & NTIOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.19 per share, an increase this year of $0.47 per share, and an increase next year of $0.77 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
National Bank of Canada Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||